Clinical Study

Study of Body Composition and Metabolic Parameters in HIV-1 Male Patients

Table 4

Body composition parameters in study population.

Parameters
(mean ± SD)
ART naiveZidovudine based regimenStavudine based regimenTenofovir based regimenProtease inhibitorsP value

BMI20.85 ± 2.3521.15 ± 2.3921.48 ± 2.2820.63 ± 3.3921.22 ± 3.22P = 0.917
Total visceral fat (in Kgs)4.09 ± 3.665.18 ± 4.465.11 ± 3.926.20 ± 4.166.21 ± 4.79P = 0.467
Total body fat (in %)13.60 ± 4.7112.25 ± 5.8113.82 ± 5.6414.96 ± 5.9616.63 ± 7.71P = 0.172
Total body water (in %)59.80 ± 9.7361.98 ± 7.8661.4 ± 6.6358.90 ± 4.9157.64 ± 7.69P = 0.318
Total muscle mass (in Kgs)45.05 ± 4.1047.69 ± 3.5347.5 ± 5.1444.46 ± 6.6344.56 ± 5.05P = 0.070
Total bone mass (in Kgs)2.52 ± 0.232.69 ± 0.342.73 ± 0.832.45 ± 0.322.50 ± 0.24P = 0.200
Waist-hip ratio0.87 ± 0.020.85 ± 0.040.87 ± 0.030.86 ± 0.040.91 ± 0.04P = 0.001